Aims/hypothesis Prenatal exposure to excess glucocorticoids associates with low birthweight in rodents, primates and humans and its involvement in programming glucose homeostasis is suspected. Our aim was to further dissect the role of glucocorticoids on beta cell development and function in mice. Methods Using the model of maternal general food restriction during the last week of pregnancy, we thoroughly studied in the CD1 mouse-mothers and fetal and adult offspring-the pancreatic, metabolic and molecular consequences of maternal undernutrition associated with excess glucocorticoids. The specific involvement of the glucocorticoid receptor (GR) was studied in mutant fetuses lacking GR in pancreatic precursors or mature beta cells. Results Maternal general food restriction in the mouse is associated with decreased maternal glucose and increased corticosterone levels. Fetuses from underfed dams had increased corticosterone levels, decreased pancreatic endocrine gene expression but increased exocrine gene expression and a lower beta cell mass. The offspring of these dams had a low birthweight, permanent postnatal growth retardation and, as adults, impaired glucose tolerance, decreased beta cell mass (−50%) and massively reduced islet expression (−80%) of most of the genes involved in beta cell function (e.g. Pdx1, Sur1 [also known as Abcc8], insulin). Moreover, using mutant fetuses lacking GR in pancreatic precursors or beta cells we show that the deleterious effect of undernutrition on fetal beta cell development requires the presence of the GR in pancreatic precursor cells. Conclusions/interpretation These results demonstrate the crucial role of excess fetal glucocorticoids and the importance of GR signalling in progenitor cells to programme beta cell mass and dysfunction.
Introduction
The concept of the early-life origins of adult diseases or fetal programming describes the process whereby a factor at a critical or sensitive window of development exerts effects that persist throughout life. Prenatal exposure to an adverse environment permanently affects organ and tissue structure and function and ultimately leads to increased susceptibility to complex metabolic disorders. In fact, low birthweight-a general feature of fetal undernutrition-is strongly associated with a higher risk of developing chronic diseases such as type 2 diabetes and cardiovascular disease [1] [2] [3] [4] . Recent evidence pinpoints a role for glucocorticoids as a causal link between intrauterine growth retardation (IUGR) and the increased risk of developing glucose intolerance and type 2 diabetes in adulthood [5, 6] . In humans [7] and rodents [8] [9] [10] [11] , fetal exposure to excess maternal glucocorticoids causes low birthweight. It is also associated with the later impairment of glucose tolerance and hypertension in rats and monkeys [8] [9] [10] [11] [12] [13] . A link between glucocorticoid elevation, low birthweight and beta cell development was identified in a rat model of maternal general food restriction (GFR) leading to decreased beta cell mass and the later occurrence of glucose intolerance in adults [14, 15] . In this model we showed that maternal GFR induces a rise in both maternal and fetal corticosterone levels [9] , which is responsible for the decreased beta cell mass and islet numbers in the rat fetus [8] . Conversely, in normally fed rat fetuses, low corticosterone levels were associated with high beta cell numbers [8] .
More recently, by inactivation of the gene encoding the glucocorticoid receptor (GR) in specific pancreatic cell populations in the mouse we showed that the effects of glucocorticoids on pancreas development indicate a decisive role of the GR on pancreatic precursor cells, as its deletion led to a twofold increase in beta cell mass in adult mice [16] .
However, the extent to which the deleterious effects of undernutrition on beta cell development can be ascribed to the activation of the glucocorticoid signalling pathway and more specifically to GR activation, or to other factors modified by the maternal nutritional status, remains unknown. To provide definitive evidence, we turned to genetic mouse models of GR gene deletion, with the prior verification that the GFR model also induced maternal and fetal glucocorticoid elevation and deleterious pancreatic consequences in the mouse. Therefore, the effects of GFR on maternal hormonal and blood glucose levels, as well as the pancreatic, metabolic and molecular consequences in the fetal and postnatal offspring were thoroughly studied in the CD1 mouse until adulthood. The key role of glucocorticoid signalling in the effects of food restriction on beta cell development was studied in mutant fetuses lacking the GR either in pancreatic precursors (GR PdxCre mouse fetuses) or in mature beta cells (GR RIPCre mouse fetuses).
Methods
Mice and food-restriction protocol CD1 Swiss pregnant mice from Charles River Laboratories (l'Arbresle, France)
had their food restricted from embryonic day (E)11.5 until E18.5 (50% of the control daily food intake, approximately 3 g/day). At parturition, food-restricted dams and their pups were fed ad libitum. Mice born from food-restricted mothers are referred to as F1-IUGR mice whereas those born from normally fed mothers are termed F1-control mice. Pregnant females were killed by decapitation at days 14.5 (E14.5), E15.5, E16.5 and E18.5 of pregnancy and the fetuses were collected. Maternal plasma glucose levels were measured immediately using a glucometer (Freestyle Papillon Mini, Abbott, Rueil-Malmaison, France) and maternal and fetal plasma corticosterone levels were measured by enzyme immunoassay (AssayMax Corticosterone ELISA kit, Abcys, Paris, France). Adult mice that lack the GR in pancreatic precursors (GR PdxCre ) or in mature beta cells (GR RIPCre ) have been previously described by Gesina et al. [16] . Controls, i.e. GR lox/lox female mice, were mated with either GR PdxCre or GR RIPCre males. Food restriction was imposed on these pregnant GR lox/lox mice from E11.5 until E18.5, as described above. Fetuses were collected on day 18.5 of pregnancy, weighed and their pancreases dissected. Morphometric measurements of beta cell fraction were performed as described below, except that the head and tail were not separated. For proliferation measurements, pregnant mice were injected 2 h before they were killed with 50 mg/kg bromodeoxyuridine (BrdU; Sigma-Aldrich, Lyon, France). Proliferation was assessed after co-staining for insulin and BrdU and was expressed as the percentage of cells positive for insulin and BrdU over the total number of insulin cells, as previously described by Avril et al. [17] .
All experiments were carried out according to the principles of laboratory animal care and the French law, Authorisation no. 75-1435 received by B. Valtat from the French Ministry of Agriculture.
Intraperitoneal glucose tolerance test (ipGTT) F1-control and F1-IUGR mice were submitted to a 16 h fast at 3 months of age. Blood was collected at time zero and at 15, 30, 60 and 120 min after an intraperitoneal injection of glucose (2 g/kg body weight). Plasma glucose levels were measured at all time points and the area under the glucose curve (AUCg) was calculated. Serum insulin levels were measured at time zero and at 15 min by ELISA (Mercodia, Uppsala, Sweden).
Insulin tolerance test Insulin was injected intraperitoneally at 1 U/kg body weight after a 5 h fast. Blood glucose levels were measured before and 15, 30, 60 and 120 min after the insulin injection. Plasma glucose levels were measured as described above.
Body composition Body composition was measured in the offspring by dual-energy X-ray absorptiometry (DEXA) using the Lunar PIXImus Mouse Densitometer (GE Healthcare, Madison, WI, USA). Mice were anaesthetised with a mixture of ketamine (85 mg/kg) and xylazine (8.5 mg/kg), administered intraperitoneally.
Pancreas processing and quantitative morphometry Pancreases from E18.5 fetuses and adult mice were dissected (five for each nutritional condition and each genotype when mutant fetuses were analysed), fixed, sectioned and prepared for immunohistochemistry performed on an Autostainer (Dako, Trappes, France) using anti-insulin antibody (Dako) followed by incubation with secondary antibodies coupled to peroxidase (Immunotech, Marseilles, France) and revealed using diaminobenzidine (DAB). In adult pancreases, the head and tail were analysed separately. Beta cell fraction was measured by morphometric measurements on eight sections per pancreas (four from the head, four from the tail or eight total from fetal pancreases) as previously described by Gesina et al. [16] . Alpha cell fraction was similarly measured at E18.5 and adult age after immunohistochemical staining with anti-glucagon antibodies (Sigma-Aldrich).
Mouse islet isolation Collagenase at 1 mg/ml (SigmaAldrich) was diluted in HBSS (Hanks' balanced salt solution) and injected in the bile duct after occlusion of the distal end just proximal to the duodenum. Pancreases were dissected out and incubated at 37°C for 20 min. After strong manual shaking, pancreatic tissue was washed four times and decanted on ice in 10% FBS HBSS. Islets were handpicked under a binocular microscope (Leica Microsystems, Wetzlar, Germany) and washed in PBS before RNA extraction.
RNA preparation and real-time PCR Total RNA was extracted from fetal pancreases and isolated adult islets using RNeasy Plus extraction kit (Qiagen, Courtaboeuf, France) according to the manufacturer's guidelines. RNA samples were reverse transcribed into cDNA using Superscript II reverse transcriptase (Invitrogen, Cergy Pontoise, France). Gene expression was quantified by real-time PCR with SybrGreen supermix in a MyIQ thermocycler (Biorad, Marnes-la-Coquette, France). Samples of islet cDNA from control mice were diluted and used to produce a standard curve. Gene expression was normalised to 18S ribosomal RNA. Primers were designed to span two exons when possible. Primers sequences are available upon request.
Statistical analysis All results are expressed as means±SD. The statistical significance of variations was tested by a Mann-Whitney non-parametric test; p<0.05 was considered significant.
Results
Perturbed maternal environment causes overexposure to glucocorticoids and growth retardation in the offspring Restricting by 50% the general food intake of pregnant mice during the last week of pregnancy resulted in decreased maternal blood glucose levels by day 14.5 of pregnancy that persisted throughout pregnancy (Fig. 1a) , whereas serum corticosterone levels were increased by 60% at the same stages of pregnancy (p<0.05; Fig. 1b) . During pregnancy, control pregnant mice gained weight while the weight of food-restricted dams remained stable from E11.5, the beginning of undernutrition (Fig. 1c) . From E14.5 to E18.5, fetuses of food-restricted dams showed a lower body weight than fetuses from control females (Fig. 1d) . Placental weight at E18.5 was also decreased (132± 11.8 mg vs 99.7±5.7 mg, p<0.05). Growth retardation was apparent at birth (body weight 1.2±0.16 g vs 1.75± 0.12 g in controls, p<0.05), and persisted at the postnatal stage ( Fig. 1e ) and until the adult stage in F1-IUGR offspring born from food-restricted mothers, both in females and males ( Fig. 1f-g ). Undernutrition did not affect litter size either at the fetal stages or at birth.
Consequences of IUGR on fetal pancreas at E18.5 As pregnant mice subjected to food restriction had increased corticosterone levels, we measured the placental expression of the gene encoding 11-beta-hydrosteroid dehydrogenase type 2 (Hsd11b2), the enzyme that protects the fetus from excess maternal glucocorticoid concentrations and fetal corticosterone levels. The production of this enzyme was dramatically decreased in the placentas of fetuses from food-restricted mice (Fig. 2a) , which showed strongly increased corticosterone levels ( Fig. 2b) , demonstrating that at the end of pregnancy the fetuses were exposed to excess glucocorticoid concentrations. In this hormonal context, these fetuses showed a 50% decrease in beta cell fraction ( Fig. 2c ) as well as a reduction in the pancreatic expression of Ins2 and pro-endocrine genes such as Pdx1, Sox9 and Ngn3 (also known as Neurog3; Fig. 2d) ; conversely, expression of exocrine genes (Ptf1a, amylase and carboxypeptidase A [Cpa2] ) and of the gene encoding the GR was strongly increased. Alpha cell fraction showed a tendency to be decreased in E18.5 fetuses from foodrestricted mice (0.13±0.01% vs 0.16±0.02% in controls), without reaching significant statistical difference (p=0.08).
Metabolic consequences in F1-IUGR adult mice Levels of plasma glucose were higher in F1-IUGR mice in both the fasted state (5.96±0.87 vs 4.03±0.19 mmol/l in F1-controls, p<0.01) and the fed state (6.93±0.89 vs 5.76±0.57 mmol/l in F1 controls, p<0.05). To better characterise glucose homeostasis in these mice, intraperitoneal glucose tolerance and insulin tolerance tests were performed, and the area under the curve for glucose (AUCg) was calculated. Glucose tolerance was impaired in F1-IUGR mice compared with F1-control mice (p<0.05; Fig. 3a) , with AUC g being significantly higher in F1-IUGR mice (Fig. 3b) . Glucose-stimulated insulin secretion during the glucose tolerance test was reduced in F1-IUGR animals (Fig. 3c ). Whole-body insulin sensitivity assessed by the insulin tolerance test showed no apparent differences between the two groups ( Fig. 3d ), but F1-IUGR mice displayed decreased adiposity (14.8±2% vs 20.2±1.8% in controls, p<0.01), as indicated by DEXA body composition measurements.
Consequences of IUGR on beta cell mass in adult pancreas
Morphometric analysis of endocrine pancreases from F1-IUGR mice showed a strongly decreased beta cell fraction (p<0.05, Fig. 4a ), and beta cell mass both absolute result and relative to body weight (p<0.05; Fig. 4b , c). This reduction was associated with a lower numerical density of islets (number of islets/cm 2 , Fig. 4d ), with essentially fewer small and large islets in F1-IUGR compared with F1-control mice (Fig. 4e ). Mean islet size was similar in the two groups (Fig. 4f) . Separate morphometric analyses of these pancreatic measures in the head and tail parts of the pancreas showed that both parts were affected (Table 1) , though the effects were more significant in the tail part of the organ. Alpha cell mass was also decreased in IUGR adult animals (0.26± 0.04 mg vs 0.45±0.09 mg in controls, p<0.05).
Consequences of IUGR on islet gene expression We next investigated in the adult islets the consequences of fetal food restriction on the expression of mRNA encoding key genes essential to beta cell function. We observed dramatic reductions (−80%) in the expression of genes involved in beta cell function, including Pdx1, Pax6, Isl1, Nkx2.2 (also known as Nkx2-2), Nkx6.1 (also known as Nkx6-1), Kir6.2 (also known as Kcnj11) and Sur1 (also known as Abcc8, p< 0.05; Fig. 5 ). Similarly, reduced levels of glucose response genes (Glut2 [also known as Slc2a2] and glucokinase) and the two genes encoding insulin (Ins1 and Ins2) were also observed. We noted no significant differences in the expression of genes encoding glucagon, somatostatin, pancreatic polypeptide (PP) or ghrelin.
GR is required for the negative effects of glucocorticoid on beta cell development As maternal GFR generates gluco- corticoid excess, which is associated with a decreased beta cell mass and function in the offspring, we questioned whether the absence of glucocorticoid signalling through the GR would alter fetal beta cell development, and if so whether this development would be sensitive to the effects of maternal GFR. To this end we generated normally fed or underfed fetuses lacking the GR in either pancreatic precursor cells (called GR PdxCre ) or mature beta cells (called GR RIPCre ). Control (GR lox/lox ) females mated with either GR PdxCre or GR RIPCre males were subjected or not subjected to food restriction from day E11.5 of pregnancy. At E18.5, fetuses were collected from normally fed GR lox/lox or from food-restricted GFR-GR lox/lox females carrying half control (i.e. GR + ) fetuses and half GR PdxCre or GR RIPCre fetuses. In line with CD1 mouse dams, the underfed GR lox/lox dams (C57Bl/6 background) showed 1.6-fold increased corticosterone concentrations compared with the normally fed GR lox/lox dams (data not shown). Normally fed GR PdxCre mutant fetuses that lacked the GR in pancreatic precursors cells exhibited increased beta cell fraction at E18.5 compared with their control GR lox/lox littermates (Fig. 6a) . Normally fed GR RIPCre mutant fetuses that had a GR deletion in mature beta cells showed a beta cell fraction similar to controls (Fig. 6a) . Interestingly, increased beta cell fraction in GR PdxCre fetuses was associated with a twofold increased beta cell proliferation compared with control fetuses, as shown by BrdU incorporation in beta cells (Fig. 6b-d) . Thus, the absence of GR in pancreatic precursors, but not in mature beta cells, increases the fetal beta cell fraction, possibly through increased proliferation. We then asked if the effects of GFR, which include the development of excess glucocorticoid concentrations, would be mediated by the GR. In this abnormal hormonal environment, GR lox/lox fetuses from underfed GFR females showed a decreased beta cell fraction vs those from normally fed females (Fig. 6a) , confirming the deleterious effect of undernutrition on beta cell development. GR RIPCre fetuses from underfed GFR females displayed a similarly decreased beta cell fraction compared with the normally fed mutant fetuses. In contrast, in GFR-GR PdxCre fetuses with no GR in precursor cells, food restriction had no effect on beta cell fraction (Fig. 6a) . This increased beta cell fraction was associated with a highly increased beta cell proliferation compared with their food-restricted GR lox/lox littermates (Fig. 6b) . These results clearly demonstrate that the deleterious effects of undernutrition-induced glucocorticoid excess on beta cell expansion require the presence of the GR in precursor cells. Interestingly, undernutrition reduced fetal body weight in all groups of fetuses irrespective of their genotype (Fig. 6e) , underlining that suppression of glucocorticoid signalling in pancreatic precursor cells may protect and enhance beta cell mass but not fetal body weight during undernutrition.
As the majority of the mutant offspring of mice subjected to GFR did not survive after birth, the long-term metabolic and pancreatic consequences of fetal undernutrition in these mutants could not be assessed.
Discussion
Low birthweight is associated with increased susceptibility to chronic diseases such as diabetes and hypertension later in life. Prenatal exposure to excess glucocorticoids is suspected to be causal in the association between low birthweight and the programming of glucose homeostasis, at least in rodents and non-human primates [8, 12, 13] . More specifically, our hypothesis is that these hormones impair beta cell development and thereby later beta cell expansion and function. We adapted the rat model of maternal GFR to the mouse, with the aim of further dissecting the role of glucocorticoids in beta cell development using mutant mice. First we thoroughly studied, in CD1 mouse offspring, the fetal and long-term pancreatic, metabolic and molecular consequences of fetal undernutrition associated with overexposure to glucocorticoids. Gr Fig. 2 Maternal undernutrition impairs fetal endocrine but favours exocrine pancreas development. a Placental expression of Hsd11b2 was measured in placenta at stage E18.5. b Corticosterone levels were measured in control (white bars) and food-restricted (black bars) fetuses at E18.5. c Beta cell fraction at E18.5 was measured morphometrically after immunohistochemistry for insulin on pancreatic sections from control (white bars) and food-restricted (black bars) fetuses. d Expression of both exocrine and endocrine genes was measured in the pancreases of fetuses at E18.5 by real-time PCR. Gene expression was normalised to control pancreas values. All values are means±SD. *p<0.05, **p<0.01, ***p<0.001, when comparing fetuses from food-restricted (black bars) mice with fetuses from control (white bars) mice using the Mann-Whitney non-parametric test (n=5 per group for placental and pancreas gene expression; n=4-5 fetuses per pregnant female for corticosterone levels; n=3 for beta cell fraction)
The results reported here show that maternal general food restriction during the last week of pregnancy is associated with increased corticosterone levels and leads in the offspring to low birthweight, growth retardation, impairment of glucose tolerance, permanently decreased beta cell mass and reduced expression of several genes involved in beta cell function. Moreover, we show that the deleterious effect of undernutrition on fetal beta cell development associated with low birthweight requires the presence of the glucocorticoid receptor in pancreatic Maternal food restriction in the CD1 mouse leads to increased maternal plasma corticosterone concentrations as early as 3 days after starting the restriction (embryonic day 14.5). The placental mRNA levels of Hsd11b2, encoding the enzyme which protects the fetus from excess maternal glucocorticoids, are greatly decreased and fetal plasma corticosterone concentrations are drastically increased at E18.5, demonstrating that fetuses are exposed to excess glucocorticoid concentrations. As in rats [8] , fetal beta cell fraction is strongly decreased. Here, we propose that this decreased beta cell fraction results from a shift in the pancreatic differentiation process towards an exocrine fate, as underlined by the increased expression of genes encoding exocrine markers (Ptf1a, amylase, carboxypeptidase A) and the decreased expression of genes encoding endocrine or pro-endocrine markers (Pdx1, Sox9, Ngn3 and Ins2). Thus, the alteration of beta cell fraction may arise from a decreased number of precursor cells expressing Ngn3 and Pdx1. These data are consistent with the modulation of the exocrine/endocrine differentiation balance by glucocorticoids previously shown by us in vitro using rat pancreatic buds treated with dexamethasone [16] .
As the production of new beta cells in adulthood is low, any deficiency occurring in utero could compromise beta cell mass expansion, contributing to beta cell failure and favouring glucose intolerance later in life. This is indeed what happened in the adult offspring of the underfed mouse dams in this study. These offspring were hyperglycaemic, Table 1 Comparative analysis of beta cell morphometrical variables in the head and the tail parts of the pancreases from adult F1-control and F1-IUGR mice Results are expressed as means±SD *p<0.05, **p<0.01 when comparing F1-IUGR with F1-control mice using the Mann-Whitney non-parametric test (n=6)
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Is l1 both in the fasted and fed states, with decreased fasting insulin levels; glucose intolerance was associated with a defect in glucose-stimulated insulin release but the offspring had normal peripheral insulin sensitivity. The hyperglycaemia and the hypoinsulinaemia are indicative of altered insulin secretion that could arise from a defect in beta cell mass and/or beta cell function. In F1-IUGR adult offspring, beta cell mass was markedly decreased, both in absolute terms and when expressed relative to body weight, even though the animals were smaller. Interestingly, alpha cell mass was also decreased as a consequence of decreased islet numbers with normal glucagon mRNA levels, suggesting that the amount of glucagon per cell was unchanged whereas that of insulin was decreased. In parallel, we showed that altered insulin secretion may arise from drastically decreased expression of several key beta cell function genes such as Pdx1, Nkx2.2, Ins1 and Ins2 but also genes essential to glucose sensing such as Glut2, glucokinase and the subunits of ATP-sensitive K + channels Kir6.2 (the inwardly rectifying K + channel) and Sur1 (sulfonylurea receptor 1). Our model suggests that the metabolic phenotype of the adult offspring originates from a default of beta cell development in utero, resulting in a permanent reduction of beta cell mass and function, and leading to altered glucose homeostasis at an adult age.
A 50% reduction in maternal food intake during pregnancy led to decreased fetal weight from E14.5. Mouse pups were born with birthweight decreased by 20-30%, a drastic reduction compared with the 15% reduction observed in the rat pups with the same diet [18] . This growth retardation persisted throughout life, was associated with decreased adiposity and had a more severe impact on males than females. Our data are in contrast to those of JimenezChillaron et al., [19] obtained using a murine model where in utero underfed offspring exhibit 'catch-up' growth, fed hyperinsulinaemia and develop glucose intolerance without reduction in beta cell mass. In this other model, the metabolic dysfunction of underfed offspring arises from the inability of islets to modulate insulin secretion relative to ambient glucose and a default of glucokinase/hexokinase activity. The reasons for the discrepancies between these two mouse models of 50% maternal general food restriction are unclear, but the diet used here contains 5% fat whereas the diet used by the other group contains 9% fat. The difference between the two diets may affect fat storage in the mothers and modify fat content in the milk during suckling. In fact, the catch-up growth in the other model has been recently shown to be associated with increased gonadal fat, lipogenic gene expression and adipocyte size [20] , whereas our adult animals showed decreased adiposity. Alternatively, the differences observed between the two models may also arise from the duration of food restriction, which in our model starts 1 day earlier [19] .
In the present work, undernutrition was associated with increased maternal and fetal corticosterone concentrations that can be responsible for the programmed alterations of the fetal beta cells. In a previous study in rats, we adrenalectomised the dams to show the effect of maternal glucocorticoid elevation on fetal beta cell development [8] .
Here, we used a more specific approach of genetic dissection in mice. We studied the impact of maternal undernutrition on genetically modified mice in which the GR is specifically deficient in either pancreatic precursor cells (GR PdxCre ) or mature beta cells (GR RIPCre ). As previously described in adults and neonates [16] , the absence of GR in pancreatic precursors, but not in mature beta cells, increases fetal beta cell fraction in normally fed GR PdxCre mutants and unexpectedly also increases beta cell proliferation. The ability of glucocorticoids to regulate cell proliferation plays an important role in their therapeutic anti-inflammatory and immunosuppressive effects, and further work is required to define the mechanisms involved in the upregulation of beta cell proliferation when glucocorticoid signalling is suppressed. An important issue to address is whether the effects of GFR on fetal beta cell fraction are mediated by the GR. Here, we clearly demonstrate that the deleterious effects of undernutrition and thereby excess glucocorticoid concentrations on beta cell expansion require the presence of the GR in the precursor cells. Moreover, the effects seen with GR PdxCr but not GR RIPCre indicate that GR signalling is important between progenitors and insulin-positive cells, though the precise stage at which this occurs is not yet clear. The data from the GFR model showing decreased Ngn3 expression and increased exocrine markers suggest that it could be earlier than endocrine commitment, but the normal pancreas development seen at E15.5 in GR −/− mutants [21] makes this hypothesis rather unlikely and places the glucocorticoidsensitive period between E15.5 and E18.5 in the mouse. Interestingly, undernutrition reduced fetal body weight in all groups of fetuses, irrespective of their genotype, underlining that suppression of glucocorticoid signalling in pancreatic precursor cells may protect and enhance beta cell mass but not fetal body weight during GFR, a result that was expected as the deletion of glucocorticoid signalling is pancreas specific. Unfortunately, the longterm metabolic and pancreatic consequences of fetal undernutrition could not be performed on these mutants because of their early postnatal death. So far, the reasons for the increased lethality in this mouse strain remain unclear and could be either maternal or fetal. In these mice, 50% food restriction may have stronger consequences than in the CD1 as C57BL/6 mice are smaller and may have less energy storage capacity, preventing the dams from facing the increased metabolic demand of nurturing and lactating. Alternatively, fetal growth velocity seems to be more altered by undernutrition with the C57BL/6 genetic background, as mutant fetuses already show a profound growth retardation at E18.5 (−30%) compared with −20% in the CD1 fetuses at the same stage and with a similar gestation length. It is likely that this blunted growth is incompatible with postnatal life with the C57BL/6 genetic background.
In conclusion, we present here genetic evidence for the importance of glucocorticoid signalling in mediating the deleterious effects of undernutrition in programming fetal beta cell development. Low birthweight associated with excess glucocorticoid exposure during fetal life alters beta cell development, provided that the GR is present in the pancreatic precursors. This primitive impact of glucocorticoids on beta cell development permanently programmes the functional beta cell mass and thereby adult glucose tolerance. These results strengthen the notion that glucocorticoids are potent negative regulators of beta cell development and function in mice. Moreover, it suggests that humans who received dexamethasone treatment during fetal life in specific situations such as prevention of ambiguous genitalia in congenital adrenal hyperplasia syndrome [22] may undergo altered beta cell development, inasmuch as both the production of cortisol de novo by the human fetus and the expression of the GR in the human fetal pancreas occur at exactly the same time as pancreatic progenitors are committing to the endocrine lineage [23, 24] . These individuals treated in utero with glucocorticoids may consequently be at increased risk of developing diabetes later in life and should therefore be followed closely.
